RANBAXY LABS LTD
GenericsRANBAXY LABS LTD is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Dermatology.
RANBAXY LABS LTD's Key Drugs
RANBAXY LABS LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
RANBAXY LABS LTD's Recent FDA Approvals
New NDA/BLA approvals for RANBAXY LABS LTD over the last two years — novel drugs only, excluding generics and label supplements.
RANBAXY LABS LTD's Therapeutic Areas
RANBAXY LABS LTD's approved drugs and pipeline span 5 therapeutic areas, led by Infectious Disease and Gastroenterology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
RANBAXY LABS LTD's Top Competitors
RANBAXY LABS LTD's closest competitors by therapeutic-area and drug-target overlap include Pfizer, APOTHECON, and PHARMACIA AND UPJOHN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
RANBAXY LABS LTD Pipeline Snapshot
Active clinical trials for RANBAXY LABS LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1964-11-06
- Latest
- 2018-11-06
- Applications
- 53